このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Virtual-reality for Upper Limb Rehabilitation in People With Parkinson's Disease

2021年12月6日 更新者:Prof. Massimo Filippi

Clinical and Brain Functional MRI Effects of a Rehabilitative Training of Upper Limb Using Immersive Virtual Reality in People With Parkinson's Disease

The aim of this study is to assess the effect of 8-week physiotherapy training using immersive virtual reality (VR-training) compared to a physiotherapy training performed in a real setting (RS-training) on handwriting and touch screen technology-based activities, brain functional activity and cognition in patients with Parkinson's disease (PD). Both groups will perform upper limb exercises focused at improving movement amplitude and speed during several activities such as writing and using touch screen-technology. Participants randomized to VR-training (N=20) will perform exercises under the augmented visual feedback induced by the VR aimed at stimulating movement amplitude and speed. Participants randomized to RS-training (N=20) will perform exercises in a real setting.

Before training, after training (8 weeks) and at 3-month follow-up (20 weeks), subjects with PD will undergo clinical evaluations (neurological, physiotherapy and neuropsychological) while taking their regular anti-parkinsonian drugs (on-medication state). MRI scans will be acquired at each time-point to assess brain activity reorganization during off state (MRI scans will be acquired at least 12 hours after the regular evening dopaminergic therapy administration to mitigate the pharmacological effects on neural activity). A sample of matched healthy subjects (N=15) will undergo clinical, physiotherapy, neuropsychological and MRI assessments only at study entry as a benchmark.

調査の概要

研究の種類

介入

入学 (予想される)

55

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

      • Milan、イタリア、20132
        • 募集
        • IRCCS San Raffaele
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

85年歳未満 (子、大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion criteria for PD patients:

  • Diagnosis of idiopathic Parkinson's disease
  • H&Y scale ≤ 3 while on medication
  • Age ≤ 85 years
  • Right-handedness with the Edinburgh Handedness Inventory Quotient
  • Right-side involvement according to H&Y and Movement Disorder Society Unified Parkinson's Disease Rating Scale III (MDS-UPDRS III)
  • Handwriting difficulty defined by a score greater than or equal to 1 on item II.7 of the MDS-UPDRS
  • Oral and written informed consent to study participation

Inclusion criteria for healthy controls:

  • Sex-matched and age-matched with PD patients;
  • Right-handed;
  • Oral and written informed consent to study participation.

Exclusion criteria for PD patients:

  • Mini-Mental State Examination lower than 24;
  • Visual impairments that interfere with the immersive virtual environment;
  • (Other) upper limb deficits impeding handwriting;
  • History of (other) systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
  • Family history of neurodegenerative disorders;
  • History of alcohol and/or psychotropic drug abuse;
  • Contraindications for MRI;
  • Denied oral and written informed consent to study participation.

Exclusion criteria for healthy controls:

  • Mini-Mental State Examination lower than 28;
  • Visual impairments that interfere with the immersive virtual environment;
  • History of systemic, neurologic, psychiatric diseases, head injury and cerebrovascular alterations visible at an MRI scan;
  • History of alcohol and/or psychotropic drug abuse;
  • Contraindications for MRI;
  • Denied oral and written informed consent to study participation

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:VR-training
Upper limb/handwriting exercises in an immersive virtual reality setting

Progressively difficult multimodal physiotherapy under the augmented visual feedback induced by the VR. Participants will wear a head-mounted display and their upper limb movements during the training will be captured by a motion tracker. Patients will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) under the augmented visual feedback provided by the use of VR in increasingly wide range of movement; active upper limb multi-joints movements under the augmented visual feedback provided by the use of VR (following trajectories designed in the virtual space - movement involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage in VR context on a tablet and a smartphone.

30 minutes of exercises, 2 times a week, for 8 weeks.

アクティブコンパレータ:RS-training
The same upper limb/handwriting exercises in a real setting

Participants will perform progressively difficult multimodal physiotherapy in a real setting. Participants will be encouraged to perform their upper limb movements during the training in order to perform faster and ampler movements. They will perform: repetition of movements of upper limb single joints (shoulder, elbow and wrist) in increasingly wide range of movement under the feedback provided by therapist; active upper limb multi-joints movements under the feedback provided by the therapist (following trajectories designed on a table or on a blackboard - movements involving shoulder, elbow and wrist joints) and handwriting tasks and touch screen technology usage under the supervision of the therapist.

30 minutes of exercises, 2 times a week, for 8 weeks.

他の:Healthy subjects
Age- and sex-matched healthy subjects recruited to compare clinical and fMRI characteristics at baseline.
Only baseline evaluations, without longitudinal assessment

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Letters amplitude
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Changes in letters amplitude during a repetitive handwriting task on a writing tablet. Higher amplitude reflects a better performance. Assessment during ON medication phase
Baseline, after 8 weeks of training and after 3-month follow-up

二次結果の測定

結果測定
メジャーの説明
時間枠
Systematic Screening of Handwriting Difficulties test (SOS)
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Systematic Screening of Handwriting Difficulties test assesses handwriting quality on a paper sheet. Patients copy 5 sentences. Handwriting quality is evaluated using five items: (i) fluency in letter formation; (ii) connections between letters; (iii) regularity of letter size; (iv) space between words; and (v) straightness of the sentence. Each item is evaluated with a score ranging from zero to two. A score of zero is given when the handwriting problem does not occur or is only present in one sentence. A score of one is given if the problem appears in two or three sentences and a score of two when the problem occurs in more than three sentences. The total SOS-score is the sum of the scores on the five criteria with a range from 0 to 10, with higher scores reflecting worse quality of handwriting. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Systematic Screening of Handwriting Difficulties test (SOS) on a tablet
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
SOS will be repeated also on a tablet with a touch-screen pen in order to assess handwriting quality on tablet. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Repetitive Prewriting task on tablet
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Repetitive Prewriting task consists in writing specific loop figures, which reflect the essential components of writing on a tablet with a pen. Movement amplitude and speed will be recorded. Higher amplitude and speed reflect better results. Assessment during ON medication phase
Baseline, after 8 weeks of training and after 3-month follow-up
Funnel task on tablet
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Funnel task consists in alternating upstroke and down stroke writing-like movements at varying amplitudes on a tablet with a pen to assess freezing during writing. Movement amplitude and speed will be recorded. Higher amplitude and speed reflect better results, number of interruptions during writing will be recorded to assess freezing severity. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Brain functional changes during hand-tapping in a virtual reality setting
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Changes in functional MRI brain activity assessed during hand-tapping task in a virtual reality setting. Assessment during OFF medication phase, at least 12 hours after last medication assumption.
Baseline, after 8 weeks of training and after 3-month follow-up
Brain functional changes during hand-tapping in a real setting
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Changes in functional MRI brain activity assessed during hand-tapping task in a real setting. Assessment during OFF medication phase, at least 12 hours after last medication assumption.
Baseline, after 8 weeks of training and after 3-month follow-up
Hand tapping task
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Amplitude and speed of hand tapping performed with electromagnetic sensors placed on the hand. Higher movement amplitude and speed reflect better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Finger tapping task
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Amplitude and speed of finger tapping performed with electromagnetic sensors placed on the hand. Higher movement amplitude and speed reflect better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Velocity of swipe-slide finger movements on a screen
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Velocity of swipe-slide movements of the fingers on a smartphone screen. Movements usually employed to unlock and use smartphones/tablets. Number of movements in a given time and velocity of movements reflect better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Velocity of finger tapping movements on a screen
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Velocity of tapping movements of the fingers on a smartphone screen. Movements usually employed to unlock and use smartphones/tablets. Number of movements in a given time and velocity of movements reflect better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Rubber Hand Illusion paradigm
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Rubber hand illusion assesses bodily self-awareness and sense of agency. Patients report in a 10-points level scale their agreement relatively to nine statements reflecting how is the perception of their real hand relative to the rubber hand. Higher scores reflect higher illusion. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Cambridge Neuropsychological Test Automated Battery (CANTAB)
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
This battery of cognitive tests assesses executive-attentive functions, memory and visuospatial abilities. Lower reaction time and greater number of correct responses reflect better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up
Parkinson's Disease Questionnaire (PDQ-39) score
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Parkinson's Disease Questionnaire investigates the quality of life of PD patients. It includes 39 questions with 5 possible answers (never, occasionally, sometimes, often, always) and 8 sub-items related to mobility, ADLs, emotional well-being, signs of discouragement, social support, cognitions, communication and bodily discomfort. The maximum score is 100 and a low score is an indicator of a good quality of life.
Baseline, after 8 weeks of training and after 3-month follow-up
Manual Ability Measure (MAM-36) questionnaire
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
The Manual Ability Measurement (MAM-36) includes 36 items assessing perceived ease or difficulty in performing common tasks (e.g. eating, dressing, button clothes). Items are rated on a 4-point scale from one "I cannot do it" to four "I can do it without any problem". A zero-response option is also included, indicating tasks that are almost never performed, with or without hand impairment. Scores on the 36 items are summed to create a total score with a range from 36 to 144, with higher scores reflecting higher ability.
Baseline, after 8 weeks of training and after 3-month follow-up
Purdue Pegboard Test (PPT)
時間枠:Baseline, after 8 weeks of training and after 3-month follow-up
Purdue Pegboard Test is a widely used test to assess upper limb motor function and activity. Patient is asked to place pegs vertically in a board in front of him as fast as possible for 30 seconds. Higher number of placed pegs reflects a better performance. Assessment during ON medication phase.
Baseline, after 8 weeks of training and after 3-month follow-up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2021年5月17日

一次修了 (予想される)

2024年3月1日

研究の完了 (予想される)

2024年6月1日

試験登録日

最初に提出

2021年5月3日

QC基準を満たした最初の提出物

2021年5月3日

最初の投稿 (実際)

2021年5月6日

学習記録の更新

投稿された最後の更新 (実際)

2021年12月7日

QC基準を満たした最後の更新が送信されました

2021年12月6日

最終確認日

2021年12月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

パーキンソン病の臨床試験

  • Adelphi Values LLC
    Blueprint Medicines Corporation
    完了
    肥満細胞性白血病 (MCL) | 攻撃的な全身性肥満細胞症 (ASM) | SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD) | くすぶり全身性肥満細胞症 (SSM) | 無痛性全身性肥満細胞症 (ISM) ISM サブグループが完全に募集されました
    アメリカ
3
購読する